Trial intelligence / Profile preview

IZN-6NVS in Atrophic Vaginitis or Desquamative Inflammatory Vaginitis

NCT02313545Phase 2Completed

Sponsor
Izun Pharmaceuticals
Start
Dec 2014
Primary completion
Dec 2016
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of IZN-6NVS in atrophic vaginitis, desquamative inflammatory vaginitis (DIV), sponsored by Izun Pharmaceuticals. Started Dec 2014; status: completed.

02

Drugs

IZN-6NVS
03

Conditions

atrophic vaginitisdesquamative inflammatory vaginitis (DIV)

Beyond the preview

Go deeper on NCT02313545.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02313545.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call